BackSanofi Overview

Sanofi Receivables

Latest receivables for SAN.PA: $330M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$326.00M
↓ 34.41% YoYΔ $-171.00M vs prior year quarter

Peer trimmed avg / median

Loading

Sanofi Receivables History

Loading

Sanofi vs. peers: Receivables Comparison

Loading

Sanofi Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sanofi (SAN.PA) FAQ

The latest receivables for SAN.PA is $330M as of September 2026. That compares with $500M in the prior-year period — down 34.4% year over year. Investors often review this figure alongside Sanofi's historical trend and sector peers before judging valuation or financial health.

Over the past year, SAN.PA's receivables moved from $500M to $330M — a 34.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sanofi's operating scale or balance-sheet position.

A receivables figure of $330M for SAN.PA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SAN.PA's receivables ($330M), review year-over-year change from $500M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sanofi's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers